NSAIDs may reduce PCa risk, prospective data show

November 1, 2001

Baltimore-Nonsteroidal anti-inflammatory drugs may reduce therisk of prostate cancer, suggests a study completed by Johns Hopkins Hospitalin Baltimore, the National Institute on Aging, and Merck Research Labs.The researchers stress that the findings are suggestive but not definitive.

Related Content:

Drug Therapy | News